AXSM

AXSOME THERAPEUTICS INC.

AXSM·05464T104·US·Common Stock·Healthcare - Biotechnology-13D/G

AXSM (AXSOME THERAPEUTICS INC.) is held by 191 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($661.3M), VANGUARD PORTFOLIO MANAGEMENT LLC ($347.9M), VANGUARD CAPITAL MANAGEMENT LLC ($327.5M). Net institutional sentiment: Mixed.

191
Holders
(17 Elite)
$5.4B
Total Value
58% (192)
Consensus
112 buying - 80 selling
13F: Insider & Congress:
AXSMSmart Money Verdict
View all
Held by 191 funds
17 elite
Who's Trading
InsiderJLJacobson Mark L.Exercise 233 shMay 5, 2026
InsiderJLJacobson Mark L.Sell $53KMay 5, 2026
InsiderJLJacobson Mark L.Exercise 5K shMay 4, 2026
InsiderJLJacobson Mark L.Sell $1.0MMay 4, 2026
InsiderMAMaizel AriSell $1.4MApr 22, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 26, 2026
InsiderCMColeman MarkSell $4.0MFeb 26, 2026
InsiderJLJacobson Mark L.Sell $5.7MFeb 26, 2026
InsiderPNPizzie NickSell $2.3MJan 22, 2026
ActivistRTW Investments, LPRTW Investments, LP3.1%Aug 14, 2025
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
3.9M(-0.0%)$661.3M0.0%+164.95%
0
New
2.1M$347.9M0.0%+42.52%
43
New
1.9M$327.5M0.0%+42.52%
43
Increased
1.6M(+32.6%)$264.9M0.0%+97.14%
39
Decreased
1.3M(-12.8%)$222.6M0.0%+93.05%
0
Increased
1.3M(+1.9%)$219.3M0.0%+108.48%
31
Increased
1.2M(+15.1%)$196.6M0.0%+233.17%
35
Decreased
1.1M(-6.3%)$193.6M0.0%+140.41%
0
Increased
986,809(+3.0%)$166.8M0.0%+176.67%
31
Increased
865,958(+85.0%)$146.4M0.2%+12.88%
56
Decreased
812,809(-17.9%)$137.4M0.2%+57.13%
0
Increased
737,578(+100.7%)$124.7M0.2%+76.63%
58
Increased
603,465(+9.9%)$102M0.1%+73.52%
33
Decreased
598,091(-3.2%)$101.1M0.0%+89.83%
0
Increased
577,479(+1230.2%)$97.6M0.1%+46.68%
48
Increased
547,195(+54.0%)$92.5M0.0%+72.28%
42
Decreased
476,701(-3.0%)$80.6M0.0%+148.61%
0
Increased
438,490(+28.0%)$74.1M0.0%+101.79%
37
Increased
424,750(+2259.8%)$71.8M0.1%+45.25%
48
Increased
421,447(+40.1%)$71.2M0.0%+88.37%
39

Showing 1-20 of 202

1 / 11

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used